Abstract:Abstract The p53 tumor suppressor plays a critical role in maintaining genome stability. In response to genotoxic stress, p53 induces target genes for cell cycle arrest, apoptosis, and DNA repair. While p53 is the most commonly mutated gene in all cancers, it is only mutated in 20% of breast cancers. Interestingly, 70% of all breast cancer cases are estrogen receptor (ER) positive and are associated with wild type p53 expression. An ER-positive breast cancer diagnosis generally indicates good patient prognosis and treatment responsiveness with anti-estrogens such as tamoxifen. The relationship between ERα and p53 remains poorly defined. Here, we found that ERα positively regulates p53 expression. Specifically, knockdown of ERα decreases the amount of p53 along with its downstream target p21, a regulator of cell cycle arrest, in MCF7 breast cancer cells. Furthermore, we found that ERα transcriptionally regulates p53 expression via binding to the p53 promoter. Luciferase promoter reporter experiments showed that two estrogen receptor element half sites located at nt −1828 and −1611 from the p53 transcriptional start site responded to addition of ERα with increased reporter activity. Mutation of those two sites resulted in no reporter activity. To determine the biological significance of ERα regulation of p53, we found that knockdown of ERα desensitized cells to growth arrest and cell death upon treatment with DNA damage-inducing drugs in a p53-dependent manner. Conversely, cells overexpressing ERα were sensitized to growth arrest and cell death upon DNA damage-inducing drugs via the p53 pathway. Together, these results provide an insight into the reciprocal regulation of p53 and ERα at the transcript level and how their pathways interact in ER-positive breast cancers under basal and stress conditions. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1284. doi:1538-7445.AM2012-1284

Ap-2 Beta Enhances P53-Mediated Transcription Of The Alpha B-Crystallin Gene Through Stabilizing P53

AP-2β enhances p53-mediated transcription of the αB-crystallin gene through stabilizing p53

Transcriptional Regulation of Pp2a-A Alpha is Mediated by Multiple Factors Including Ap-2 Alpha, Creb, Ets-1, and Sp-1

Ck2 Phosphorylates Ap-2 Alpha And Increases Its Transcriptional Activity

Transcriptional and translational regulation of CCAAT/Enhancer Binding Protein β expression by P53

The PP2A-Aβ Gene is Regulated by Multiple Transcriptional Factors Including Ets-1, SP1/SP3, and RXRα/β.

The transcription factor CREB acts as an important regulator mediating oxidative stress-induced apoptosis by suppressing alpha B-crystallin expression

PP‐1β and PP‐2Aα modulate cAMP response element‐binding protein (CREB) functions in aging control and stress response through de‐regulation of αB‐crystallin gene and p300‐p53 signaling axis

[Research on the anti-tumor effects of CRYAB in prostate cancer]

Transcription factor AP-2α activates RNA polymerase III–directed transcription and tumor cell proliferation by controlling expression of c-MYC and p53

The role of human ADA2a in the regulation of p53 acetylation and stability

As a Novel P53 Direct Target, Bidirectional Gene HspB2/αB-crystallin Regulates the ROS Level and Warburg Effect.

P1–298: Differential Transcriptional Regulation of PEN–2 and APH–1A, Two Key Components of the Gamma–secretase Complex

Abstract 1284: Estrogen Receptor Alpha Transcriptionally Regulates P53 in MCF7 Human Breast Cancer Cells

Additional File 4: of CpG Site Methylation in CRYAA Promoter Affect Transcription Factor Sp1 Binding in Human Lens Epithelial Cells

Alpha B Crystalline Upregulates The Expression Of Matrix Metalloproteinases In Trabecular Meshwork Cells Through Tlr1/2

Abstract 5644: The impact of ATF3, JDP2, FOXR2, NAA10, FOXL2, DDX20, and p14ARF on the transactivation of p53

CBFβ-SMMHC, Expressed in M4eo Acute Myeloid Leukemia, Reduces P53 Induction and Slows Apoptosis in Hematopoietic Cells Exposed to DNA-Damaging Agents

Transcriptional Control of Human CD2AP Expression: the Role of Sp1 and Sp3

P53-Dependent Control of Transactivation of the Pen2 Promoter by Presenilins

CRY2 missense mutations suppress P53 and enhance cell growth